Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what metrics are being used to measure the success of the Palantir-powered Federated Data Platform (FDP); and whether any productivity gains or improvements to patient care have been attributed to the FDP thus far, as opposed to any other intervention.
During product development, the NHS Federated Data Platform (NHS FDP) team identified relevant usage and benefits measures for each specific product. These measures are related to the problem statement the product was designed to address and are co-developed with users.
Once a product has completed development and testing and becomes generally available, data on the usage and benefits measures at an aggregate level, across all organisations nationally, are published on the NHS FDP website. Over time, further products will become generally available on the NHS FDP, supporting the National Health Service areas of elective care, urgent and emergency care, cancer and diagnostics, operational management, and population health and neighbourhood care.
Information on the benefits derived from the NHS FDP is published each quarter by NHS England and is available at the following link:
In addition to the quantitative benefits, information from organisations on the benefits they are seeing from the NHS FDP from a qualitative perspective is collected in the form of case studies available at the following link:
https://www.england.nhs.uk/digitaltechnology/nhs-federated-data-platform/impact/case-studies/